SAXE JON S has filed 3 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 17600 shares of Vistagen Therapeutics, Inc. ($VTGN) on September 09, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 9, 2025 | Vistagen Therapeutics, Inc. | $VTGN | SAXE JON S | Director | A | Non-Qualified Stock Option (right to buy) | 17600 | $0.00 | 17,600.0000 | 29,157,733 | 9999.99% | 0.06% |
| Sept. 6, 2024 | Vistagen Therapeutics, Inc. | $VTGN | SAXE JON S | Not found | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 19,354,500 | 9999.99% | 0.07% |
| March 4, 2024 | Vistagen Therapeutics, Inc. | $VTGN | SAXE JON S | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |